{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/68135-100#drug","name":"VIMIZIM","alternateName":"elosulfase alfa","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"68135-100"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA125460"},{"@type":"PropertyValue","propertyID":"UNII","value":"ODJ69JZG85"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"0caa2565-12b2-0ad0-1f9a-273e81c3d4cc"}],"activeIngredient":"ELOSULFASE ALFA","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, SOLUTION, CONCENTRATE","manufacturer":{"@type":"Organization","name":"BioMarin Pharmaceutical Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA125460","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0caa2565-12b2-0ad0-1f9a-273e81c3d4cc","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68135-100"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T08:57:51.413Z"}}